Long-term study of the association of adipokines and glucose variability with diabetic complications

Jin Joo Cha, Hye Sook Min, Kitae Kim, Mi Jin Lee, Mi Hwa Lee, Jung Eun Kim, Hye Kyoung Song, Dae-Ryong Cha, Young Sun Kang

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background/Aims: Recent studies have suggested an important role of adipokines in the development of insulin resistance and diabetes mellitus. The clinical relevance of adipokines on long-term outcomes in patients with diabetes and chronic kidney disease is uncertain. The purpose of this study was to identify a predictable factor in patients with long-term diabetic complications. Methods: A total of 161 diabetic individuals were followed-up from 2002 to 2013. Circulating plasma levels of adiponectin, glypican-4, irisin, visfatin, and vis-it-to-visit glucose variability were measured in diabetic patients. Associations among adipokines and variable metabolic parameters and microvascular, and macrovascular complications were evaluated. Results: Plasma adiponectin and glypican-4 levels were significantly increased in patients with renal insufficiency. These adipokines were negatively associated with estimated glomerular filtration rate and positively associated with urinary albumin excretion. The relative risk of renal progression to dialysis increased independently with increasing level of adiponectin. Glypican-4 and visfatin were not predictive of any microvascular or macrovascular complications. Glucose variability increased the risk of diabetic nephropathy and cerebrovascular complications. Conclusions: Adiponectin and glypican-4 were associated with renal function and might be able to predict renal progression. Glucose variability was a predictable factor for diabetic nephropathy and cerebrovascular complications.

Original languageEnglish
Pages (from-to)367-382
Number of pages16
JournalKorean Journal of Internal Medicine
Volume33
Issue number2
DOIs
Publication statusPublished - 2018 Mar 1

Fingerprint

Glypicans
Adipokines
Adiponectin
Diabetes Complications
Nicotinamide Phosphoribosyltransferase
Glucose
Diabetic Nephropathies
Kidney
Glomerular Filtration Rate
Chronic Renal Insufficiency
Renal Insufficiency
Insulin Resistance
Dialysis
Albumins
Diabetes Mellitus

Keywords

  • Adipokines
  • Adiponectin
  • Diabetes complications
  • Glucose variability
  • Glypicans

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Long-term study of the association of adipokines and glucose variability with diabetic complications. / Cha, Jin Joo; Min, Hye Sook; Kim, Kitae; Lee, Mi Jin; Lee, Mi Hwa; Kim, Jung Eun; Song, Hye Kyoung; Cha, Dae-Ryong; Kang, Young Sun.

In: Korean Journal of Internal Medicine, Vol. 33, No. 2, 01.03.2018, p. 367-382.

Research output: Contribution to journalArticle

Cha, Jin Joo ; Min, Hye Sook ; Kim, Kitae ; Lee, Mi Jin ; Lee, Mi Hwa ; Kim, Jung Eun ; Song, Hye Kyoung ; Cha, Dae-Ryong ; Kang, Young Sun. / Long-term study of the association of adipokines and glucose variability with diabetic complications. In: Korean Journal of Internal Medicine. 2018 ; Vol. 33, No. 2. pp. 367-382.
@article{74faef38a5b1423ba358ec005bd7d891,
title = "Long-term study of the association of adipokines and glucose variability with diabetic complications",
abstract = "Background/Aims: Recent studies have suggested an important role of adipokines in the development of insulin resistance and diabetes mellitus. The clinical relevance of adipokines on long-term outcomes in patients with diabetes and chronic kidney disease is uncertain. The purpose of this study was to identify a predictable factor in patients with long-term diabetic complications. Methods: A total of 161 diabetic individuals were followed-up from 2002 to 2013. Circulating plasma levels of adiponectin, glypican-4, irisin, visfatin, and vis-it-to-visit glucose variability were measured in diabetic patients. Associations among adipokines and variable metabolic parameters and microvascular, and macrovascular complications were evaluated. Results: Plasma adiponectin and glypican-4 levels were significantly increased in patients with renal insufficiency. These adipokines were negatively associated with estimated glomerular filtration rate and positively associated with urinary albumin excretion. The relative risk of renal progression to dialysis increased independently with increasing level of adiponectin. Glypican-4 and visfatin were not predictive of any microvascular or macrovascular complications. Glucose variability increased the risk of diabetic nephropathy and cerebrovascular complications. Conclusions: Adiponectin and glypican-4 were associated with renal function and might be able to predict renal progression. Glucose variability was a predictable factor for diabetic nephropathy and cerebrovascular complications.",
keywords = "Adipokines, Adiponectin, Diabetes complications, Glucose variability, Glypicans",
author = "Cha, {Jin Joo} and Min, {Hye Sook} and Kitae Kim and Lee, {Mi Jin} and Lee, {Mi Hwa} and Kim, {Jung Eun} and Song, {Hye Kyoung} and Dae-Ryong Cha and Kang, {Young Sun}",
year = "2018",
month = "3",
day = "1",
doi = "10.3904/kjim.2016.114",
language = "English",
volume = "33",
pages = "367--382",
journal = "Korean Journal of Internal Medicine",
issn = "0494-4712",
publisher = "Korean Association of Internal Medicine",
number = "2",

}

TY - JOUR

T1 - Long-term study of the association of adipokines and glucose variability with diabetic complications

AU - Cha, Jin Joo

AU - Min, Hye Sook

AU - Kim, Kitae

AU - Lee, Mi Jin

AU - Lee, Mi Hwa

AU - Kim, Jung Eun

AU - Song, Hye Kyoung

AU - Cha, Dae-Ryong

AU - Kang, Young Sun

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Background/Aims: Recent studies have suggested an important role of adipokines in the development of insulin resistance and diabetes mellitus. The clinical relevance of adipokines on long-term outcomes in patients with diabetes and chronic kidney disease is uncertain. The purpose of this study was to identify a predictable factor in patients with long-term diabetic complications. Methods: A total of 161 diabetic individuals were followed-up from 2002 to 2013. Circulating plasma levels of adiponectin, glypican-4, irisin, visfatin, and vis-it-to-visit glucose variability were measured in diabetic patients. Associations among adipokines and variable metabolic parameters and microvascular, and macrovascular complications were evaluated. Results: Plasma adiponectin and glypican-4 levels were significantly increased in patients with renal insufficiency. These adipokines were negatively associated with estimated glomerular filtration rate and positively associated with urinary albumin excretion. The relative risk of renal progression to dialysis increased independently with increasing level of adiponectin. Glypican-4 and visfatin were not predictive of any microvascular or macrovascular complications. Glucose variability increased the risk of diabetic nephropathy and cerebrovascular complications. Conclusions: Adiponectin and glypican-4 were associated with renal function and might be able to predict renal progression. Glucose variability was a predictable factor for diabetic nephropathy and cerebrovascular complications.

AB - Background/Aims: Recent studies have suggested an important role of adipokines in the development of insulin resistance and diabetes mellitus. The clinical relevance of adipokines on long-term outcomes in patients with diabetes and chronic kidney disease is uncertain. The purpose of this study was to identify a predictable factor in patients with long-term diabetic complications. Methods: A total of 161 diabetic individuals were followed-up from 2002 to 2013. Circulating plasma levels of adiponectin, glypican-4, irisin, visfatin, and vis-it-to-visit glucose variability were measured in diabetic patients. Associations among adipokines and variable metabolic parameters and microvascular, and macrovascular complications were evaluated. Results: Plasma adiponectin and glypican-4 levels were significantly increased in patients with renal insufficiency. These adipokines were negatively associated with estimated glomerular filtration rate and positively associated with urinary albumin excretion. The relative risk of renal progression to dialysis increased independently with increasing level of adiponectin. Glypican-4 and visfatin were not predictive of any microvascular or macrovascular complications. Glucose variability increased the risk of diabetic nephropathy and cerebrovascular complications. Conclusions: Adiponectin and glypican-4 were associated with renal function and might be able to predict renal progression. Glucose variability was a predictable factor for diabetic nephropathy and cerebrovascular complications.

KW - Adipokines

KW - Adiponectin

KW - Diabetes complications

KW - Glucose variability

KW - Glypicans

UR - http://www.scopus.com/inward/record.url?scp=85043492349&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043492349&partnerID=8YFLogxK

U2 - 10.3904/kjim.2016.114

DO - 10.3904/kjim.2016.114

M3 - Article

C2 - 27809453

AN - SCOPUS:85043492349

VL - 33

SP - 367

EP - 382

JO - Korean Journal of Internal Medicine

JF - Korean Journal of Internal Medicine

SN - 0494-4712

IS - 2

ER -